Organon & Co.
OGNNYSECIK 1821825HealthcareFiscal year ends Dec 31
Latest reported revenue, Q2 FY2026$1.56bnRevenue, Q2 FY2026, three months to 2026-06-30$1.56bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 31, 2026.Latest quarter: Q2 FY2026
Three months to Jun 30, 2026, against the same quarter a year earlier.
- Revenue$1.56bnRevenue, Q2 FY2026, three months to 2026-06-30$1.56bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure−2.3% on a year earlier - Gross margin54.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $847.0m. XBRL concept
us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Revenue: $1.56bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure−0.5 pts on a year earlier - Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
- Net margin6.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $108.0m. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Revenue: $1.56bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure−2.2 pts on a year earlier - Diluted EPS$0.40Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.40 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure−28.6% on a year earlier - Free cash flow$65.0mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $107.0m. XBRL concept
us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001628280-26-051230. Derived: 6-month figure less the 3-month figure.Capital expenditure: $42.0m. XBRL conceptus-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001628280-26-051230. Derived: 6-month figure less the 3-month figure.Report this figure−64.1% on a year earlier
Last eight quarters
Full statements| Line item | Unit | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | 1,582Revenue, Q3 FY2024, three months to 2024-09-30$1.58bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | 1,592Revenue, Q4 FY2024, three months to 2024-12-31$1.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 1,513Revenue, Q1 FY2025, three months to 2025-03-31$1.51bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 1,594Revenue, Q2 FY2025, three months to 2025-06-30$1.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | 1,602Revenue, Q3 FY2025, three months to 2025-09-30$1.60bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | 1,507Revenue, Q4 FY2025, three months to 2025-12-31$1.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 1,460Revenue, Q1 FY2026, three months to 2026-03-31$1.46bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 1,558Revenue, Q2 FY2026, three months to 2026-06-30$1.56bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | |
| Gross margin | % | 58.3%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $923.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Revenue: $1.58bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | 56.3%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $896.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Revenue: $1.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 55.6%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $841.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Revenue: $1.51bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 54.8%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $874.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Revenue: $1.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | 53.5%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $857.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Revenue: $1.60bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | 49.2%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $741.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Revenue: $1.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 53.6%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $783.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Revenue: $1.46bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 54.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $847.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Revenue: $1.56bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | |
| Net margin | % | 22.7%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $359.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Revenue: $1.58bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | 6.8%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $109.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Revenue: $1.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 5.8%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $87.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Revenue: $1.51bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 9.1%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $145.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Revenue: $1.59bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | 10.0%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $160.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Revenue: $1.60bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | (13.6%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$205.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Revenue: $1.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 10.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $146.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Revenue: $1.46bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 6.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $108.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Revenue: $1.56bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | |
| Diluted EPS | $ per share | 1.38Diluted EPS, Q3 FY2024, three months to 2024-09-30$1.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | not reported (Diluted EPS not reported) | 0.33Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 0.56Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | 0.61Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001628280-25-050795.Report this figure | not reported (Diluted EPS not reported) | 0.55Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 0.40Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001628280-26-051230.Report this figure | |
| Free cash flow | $m | 99.0Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $141.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001628280-25-050795. Derived: 9-month figure less the 6-month figure.Capital expenditure: $42.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001628280-25-050795. Derived: 9-month figure less the 6-month figure.Report this figure | 335Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $390.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Capital expenditure: $55.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 43.0Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $75.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Capital expenditure: $32.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 181Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $220.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001628280-26-051230. Derived: 6-month figure less the 3-month figure.Capital expenditure: $39.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001628280-26-051230. Derived: 6-month figure less the 3-month figure.Report this figure | 218Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $264.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001628280-25-050795. Derived: 9-month figure less the 6-month figure.Capital expenditure: $46.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001628280-25-050795. Derived: 9-month figure less the 6-month figure.Report this figure | 96.0Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $141.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Capital expenditure: $45.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011125. Derived: 12-month figure less the 9-month figure.Report this figure | 188Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $225.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Capital expenditure: $37.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001628280-26-029532.Report this figure | 65.0Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $107.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001628280-26-051230. Derived: 6-month figure less the 3-month figure.Capital expenditure: $42.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001628280-26-051230. Derived: 6-month figure less the 3-month figure.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20212021-12-31 | FY20222022-12-31 | FY20232023-12-31 | FY20242024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $m | 6,304Revenue, FY2021, twelve months to 2021-12-31$6.30bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-26, accession 0001628280-24-006733.Report this figure | 6,174Revenue, FY2022, twelve months to 2022-12-31$6.17bn. XBRL concept us-gaap:Revenues. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Report this figure | 6,263Revenue, FY2023, twelve months to 2023-12-31$6.26bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 6,403Revenue, FY2024, twelve months to 2024-12-31$6.40bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 6,216Revenue, FY2025, twelve months to 2025-12-31$6.22bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | 62.8%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $3.88bn. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Revenue: $6.17bn. XBRL concept us-gaap:Revenues. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Report this figure | 59.8%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $3.75bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001628280-26-011125.Revenue: $6.26bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 58.0%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $3.71bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001628280-26-011125.Revenue: $6.40bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 53.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $3.31bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001628280-26-011125.Revenue: $6.22bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | |
| Net margin | % | 21.4%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $1.35bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-26, accession 0001628280-24-006733.Revenue: $6.30bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-26, accession 0001628280-24-006733.Report this figure | 14.9%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $917.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Revenue: $6.17bn. XBRL concept us-gaap:Revenues. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Report this figure | 16.3%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $1.02bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011125.Revenue: $6.26bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 13.5%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $864.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011125.Revenue: $6.40bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 3.0%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $187.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011125.Revenue: $6.22bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | |
| Diluted EPS | $ per share | 5.31Diluted EPS, FY2021, twelve months to 2021-12-31$5.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-26, accession 0001628280-24-006733.Report this figure | 3.59Diluted EPS, FY2022, twelve months to 2022-12-31$3.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Report this figure | 3.99Diluted EPS, FY2023, twelve months to 2023-12-31$3.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 3.33Diluted EPS, FY2024, twelve months to 2024-12-31$3.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 0.72Diluted EPS, FY2025, twelve months to 2025-12-31$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | |
| Free cash flow | $m | 1,968Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $2.16bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. 10-K filed 2024-02-26, accession 0001628280-24-006733.Capital expenditure: $192.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-26, accession 0001628280-24-006733.Report this figure | 662Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $858.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Capital expenditure: $196.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2025-11-10, accession 0001104659-25-108693.Report this figure | 548Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $799.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011125.Capital expenditure: $251.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 764Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $939.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011125.Capital expenditure: $175.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure | 538Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $700.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011125.Capital expenditure: $162.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011125.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2026-06-30 | $434.0m | 32,056,866 | Added+339,838 | |
| Pentwater Capital Management LP | 2026-06-30 | $245.1m | 18,100,000 | New+18,100,000 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2026-06-30 | $204.9m | 15,132,118 | Reduced−6,713,918 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-06-30 | $161.3m | 11,909,865 | Added+172,847 | |
| STATE STREET CORP | 2026-06-30 | $130.8m | 9,659,371 | Reduced−297,403 | |
| GOLDMAN SACHS GROUP INC | 2026-06-30 | $70.4m | 5,199,002 | Added+3,593,677 | |
| UBS Group AG | 2026-06-30 | $65.8m | 4,856,529 | Added+1,384,950 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-06-30 | $65.2m | 4,815,610 | Added+56,273 | |
| Man Group plc | 2026-06-30 | $56.6m | 4,180,500 | New+4,180,500 | |
| AQR Arbitrage LLC | 2026-06-30 | $52.4m | 3,880,354 | New+3,880,354 |
Recent filings
All 456 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3008:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120423 |
| 2026-10-3008:03 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001821825-26-000004 |
| 2026-07-3108:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-089008 |
| 2026-07-3108:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051230 |
| 2026-07-2317:13 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-314587 |
| 2026-07-1716:01 ET | 8-K | 8.01 Other events | 0001193125-26-307767 |
| 2026-06-1116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072953 |
| 2026-05-0408:46 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-029532 |
| 2026-04-3007:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-052165 |
| 2026-04-2706:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-178718 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 24, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter
About the filer
- CIK
- 1821825
- Tickers
- OGN
- Exchange
- NYSE
- SIC code
- 2834 Pharmaceutical Preparations
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- not reported
- Filer category
- Large accelerated filer
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 08:18 ET. Listed shows no prices and gives no investment advice.